Literature DB >> 12473298

The host-microbe interface within the gut.

Fergus Shanahan1.   

Abstract

Colonization with bacteria is critical for the normal structural and functional development and optimal function of the mucosal immune system. Unrestrained mucosal immune activation in response to bacterial signals from the lumen is, however, a risk factor for inflammatory bowel disease. Therefore, mucosal immune responses to indigenous flora require precise control and an immunosensory capacity for distinguishing commensals from pathogens. The use of germ-free animal models with selective colonization strategies combined with modern molecular techniques promises to clarify the molecular signals responsible for host-flora interactions in health and disease. At least half of the resident flora cannot be cultured by conventional techniques but are identifiable by molecular methods. Collectively, the resident flora represent a virtual organ with a metabolic activity in excess of the liver and a microbiome in excess of the human genome. An improved understanding of this hidden organ holds secrets relevant to several infectious, inflammatory and neoplastic disease mechanisms.

Entities:  

Mesh:

Year:  2002        PMID: 12473298     DOI: 10.1053/bega.2002.0342

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  70 in total

1.  Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice.

Authors:  B Sheil; J MacSharry; L O'Callaghan; A O'Riordan; A Waters; J Morgan; J K Collins; L O'Mahony; F Shanahan
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Right colon, left colon, and rectal surgeries are not similar for surgical site infection development. Analysis of 277 elective and urgent colorectal resections.

Authors:  Luca Degrate; Mattia Garancini; Marta Misani; Silvia Poli; Cinzia Nobili; Fabrizio Romano; Laura Giordano; Vittorio Motta; Franco Uggeri
Journal:  Int J Colorectal Dis       Date:  2010-10-05       Impact factor: 2.571

Review 3.  Production and Biomedical Applications of Probiotic Biosurfactants.

Authors:  Anila Fariq; Ayesha Saeed
Journal:  Curr Microbiol       Date:  2016-01-07       Impact factor: 2.188

Review 4.  Radiation enteropathy--pathogenesis, treatment and prevention.

Authors:  Martin Hauer-Jensen; James W Denham; H Jervoise N Andreyev
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-01       Impact factor: 46.802

Review 5.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

6.  Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.

Authors:  Pauline D Scanlan; Fergus Shanahan; Caitlin O'Mahony; Julian R Marchesi
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 7.  Probiotics in the management of colonic disorders.

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2007-10

8.  Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis.

Authors:  B Sheil; J McCarthy; L O'Mahony; M W Bennett; P Ryan; J J Fitzgibbon; B Kiely; J K Collins; F Shanahan
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  The Gut Mucosal Firewall and Functional Medicine.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-08

10.  High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.

Authors:  William S Mow; Carol J Landers; A Hillary Steinhart; Brian G Feagan; Ken Croitoru; Ernest Seidman; Gordon R Greenberg; Stephan R Targan
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.